Finance

Lists
Why is QURE up ७.३९%?
Dive Deeper
QURE:NASDAQ
Uniqure NV
US$ २२.५२
+७.३९%
(+१.५५) 1D
US$ २२.४९
-०.१४% (-०.०३२)
After hours
Closed: अक्टोबर १५, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QURE...
Open
US$ २१.९४
High
US$ २२.५६
Low
US$ २०.७६
Mkt. cap
१.५६ अरब
Avg. vol.
२९.१८ लाख
Volume
१६.१३ लाख
52-wk high
US$ ७१.५०
52-wk low
US$ ८.७३
EPS
-US$ ४.०५
Beta
१.०६
Shares outstanding
६.९४ करोड
No. of employees
२२१
Open
US$ २१.९४
High
US$ २२.५६
Low
US$ २०.७६
Mkt. cap
१.५६ अरब
Avg. vol.
२९.१८ लाख
Volume
१६.१३ लाख
52-wk high
US$ ७१.५०
52-wk low
US$ ८.७३
EPS
-US$ ४.०५
Beta
१.०६
Shares outstanding
६.९४ करोड
No. of employees
२२१
News stories
From web sources and news partners
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
About Uniqure NV
CEOMatt Kapusta
Employees२२१
Founded१९९८
Headquarters-
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to QURE in the past 3 months
Strong buy
Buy
8
Hold
2
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for QURE in the last 3 months.
Highest
Current US$ २२.५२
US$ ८०.०० (+२५५.२४%)
Average
US$ ५३.५७ (+१३७.८८%)
Lowest
US$ २८.०० (+२४.३३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joon Lee
UBS
Buy
Maintained
US$ ४८.००
+११३.१%
10/15/2026
Unknown Analyst
UBS
Buy
Initiated
US$ ४८.००
+११३.१%
10/14/2026
Eliana Merle
Barclays
Hold
Downgraded
US$ २८.००
+२४.३%
10/06/2026
Luca Issi
RBC Capital
Buy
Reiterated
US$ ४८.००
+११३.१%
10/02/2026
Salveen Richter
Goldman Sachs
Hold
Reiterated
US$ ३१.००
+३७.७%
09/30/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
US$ ७५.००
+२३३%
09/29/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
US$ ८०.००
+२५५.२%
09/30/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/29/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
-
-
09/29/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
09/02/2026
Sami Corwin
William Blair
Buy
Initiated
US$ ७३.००
+२२४.२%
09/02/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
US$ ६८.००
+२०२%
07/29/2026
Rudy Li
Wolfe Research
Buy
Upgraded
US$ ६५.००
+१८८.६%
07/29/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
US$ ७०.००
+२१०.८%
06/17/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Upgraded
-
-
06/17/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
US$ ३७.००
+६४.३%
05/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
US$ ९५.००
+३२१.८%
05/05/2026
Last report
२०२६ जुलाई २९
Fiscal period
Q2 2026
-€ १.०७ / -€ ०.७१
-५१.२५%miss
Revenue / Est. (EUR)
५१.२६ लाख / ४३.२० लाख
+१८.६६%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३७.०१ लाख
५५.६८ लाख
३५.६२ लाख
५८.४१ लाख
Cost of goods sold
३.२२ करोड
४.०२ करोड
३.०७ करोड
३.०७ करोड
Cost of revenue
३.२२ करोड
४.०२ करोड
३.०७ करोड
३.०७ करोड
Research and development expenses
६.९५ लाख
-५९.१६ लाख
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९४ करोड
२.१६ करोड
२.०१ करोड
१.९८ करोड
Operating expense
२.०७ करोड
१.५६ करोड
१.९९ करोड
२.६१ करोड
Total operating expenses
५.२९ करोड
५.५७ करोड
५.०६ करोड
५.६८ करोड
Operating income
-४.९२ करोड
-५.०२ करोड
-४.७१ करोड
-५.०९ करोड
Other non operating income
-७२.२२ लाख
१.८१ करोड
३७.६९ लाख
-१.६० करोड
EBT including unusual items
-७.१९ करोड
-४.१० करोड
-५.३० करोड
-७.९२ करोड
EBT excluding unusual items
-७.०१ करोड
-४.०० करोड
-५.४४ करोड
-७.८० करोड
Income tax expense
८६.२६ लाख
-३९.१६ लाख
४.८८ लाख
१८.४१ लाख
Effective tax rate
-१२.००%
९.५५%
-०.९२%
-२.३२%
Other operating expenses
५.३४ लाख
-१.४३ लाख
-१.८१ लाख
६३.६३ लाख
Net income
-८.०५ करोड
-३.७१ करोड
-५.३५ करोड
-८.११ करोड
Net profit margin
-२,१७५.८७%
-६६६.०६%
-१,५०२.९५%
-१,३८७.७६%
Earnings per share
-
-
-
-
Interest and investment income
३५.०३ लाख
५८.१३ लाख
५२.२९ लाख
५०.५१ लाख
Interest expense
-१.६७ करोड
-१.४६ करोड
-१.४० करोड
-१.४४ करोड
Net interest expenses
-१.३२ करोड
-८७.६० लाख
-८८.०२ लाख
-९३.१५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-४.५६ करोड
-४.७२ करोड
-४.४१ करोड
-४.६० करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू